Product Program year 2025 Source: CMS Open Payments

Fibryga

Biological Intensive Careemergency

Open in the dashboard

General payments

$2,299,917

647 payments

Research payments

$0

0 payments

Through program year 2025, $2,299,917 in general payments and $0 in research payments were reported against Fibryga (Intensive Careemergency).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2025 General $2,183,436 608
2024 General $115,449 10
2023 General $1,032 29

Breakdown

Who paid General payments · program years 2023–2025
  1. Octapharma USA, Inc. $2,299,917 647 payments
Top recipients General payments · program year 2025
  1. Adit Ginde Emergency Medicine · Aurora, CO $1,700,000 78% · 2 payments
  2. Grace Lim Pediatrics · Mountain View, CA $76,215 3% · 2 payments
  3. Tjorvi Perry Anesthesiology · Minneapolis, MN $57,967 3% · 53 payments
  4. Jonathan Jahr Anesthesiology · Los Angeles, CA $55,186 3% · 55 payments
  5. Daniel Katz Anesthesiology · New York, NY $53,649 2% · 2 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Emergency Medicine $1,700,781 78% · 9 practitioners
  2. Anesthesiology $316,648 15% · 149 practitioners
  3. Pediatrics $76,333 4% · 2 practitioners
  4. Surgical Critical Care Surgery $26,555 1% · 5 practitioners
  5. Clinical Pathology Pathology $21,479 <1% · 1 practitioner

The top 5 of 37 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Colorado $1,700,000 78% · 1 recipient
  2. California $138,091 6% · 56 recipients
  3. New York $77,617 4% · 26 recipients
  4. Minnesota $58,673 3% · 10 recipients
  5. Maryland $35,041 2% · 2 recipients

The top 5 of 30 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

647 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record